Related references
Note: Only part of the references are listed.Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma
Emanuele Cencini et al.
LEUKEMIA & LYMPHOMA (2018)
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03
Michael MacManus et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
Massimo Federico et al.
LANCET HAEMATOLOGY (2018)
Overestimated value of FDG-PET based bone marrow evaluation in lymphoma
Hugo J. A. Adams et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Radiotherapy of Follicular Lymphoma: Updated Role and New Rules
Joachim Yahalom
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
Massimo Federico et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma
Robert Marcus et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2006)
Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy:: 9-year follow-up
MS Czuczman et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma
JF Seymour et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University
AD Murtha et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
P Colombat et al.
BLOOD (2001)
Share Paper
